Key Metrics
Journal Specifications
Indexed in the following public directories
Scopus
SJR
- PublisherBentham
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
FAQs
Who is the publisher of Drug Metabolism Letters? 
The publisher of Drug Metabolism Letters is Bentham.
How can I view the journal metrics of Drug Metabolism Letters on editage? 
For the Drug Metabolism Letters metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Drug Metabolism Letters? 
The eISSN number is 1874-0758 and pISSN number is 1872-3128 for Drug Metabolism Letters.
What is the focus of this journal? 
The journal covers a wide range of topics inlcuding CYP3A4, Assay, Herb-drug interactions, Midazolam, Bioequivalence, Oral administration, Small intestine, CYP2C19, CYP2D6, Doxorubicin, Active metabolite, Protein adducts, CYP2B6, Drug metabolism, Cell culture, Cytochrome P450.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.